First Covid-19 Vaccine Trial in Africa Will Include HIV Patients
- South Africa to test Oxford-developed vaccine in 2,000 people
- Trial helps ensure access to safe vaccine for population
Photographer: Alex Edelman/AFP via Getty Images
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
South Africa will begin a coronavirus vaccine trial on Wednesday, the first such test on the continent, with its 2,000 volunteers planned to include some living with HIV.